HaloSource Inc Update on Fundraising (4816F)
May 18 2017 - 1:01AM
UK Regulatory
TIDMHAL TIDMHALO
RNS Number : 4816F
HaloSource Inc
18 May 2017
18 May 2017
THIS ANNOUNCEMENT IS NOT FOR DISTRIBUTION, DIRECTLY OR
INDIRECTLY, TO US PERSONS OR IN OR INTO THE UNITED STATES
(INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED
STATES AND THE DISTRICT OF COLUMBIA), CANADA, AUSTRALIA, JAPAN OR
THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO
SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS
OF SUCH JURISDICTION.
HaloSource, Inc.
("HaloSource" or the "Company")
Update on Fundraising
HaloSource Inc. (HAL.LN, HALO.LN), the global clean water
technology company traded on London Stock Exchange's AIM market,
refers to its previous announcement of 21 April 2017 in relation to
the conditional issue of new common shares (the "New Common
Shares") to raise approximately GBP1.9 million ($2.3 million) (the
"Fundraise").
The Company is pleased to announce that the Company has obtained
the requisite numbers of waivers of existing shareholders to (a)
amend the articles of incorporation to increase the authorised
share capital of the Company; and (b) issue the New Common Shares
without having to make a pre-emptive offer to existing
shareholders.
The Fundraise remains conditional on one of the key cornerstone
investors to the Fundraise receiving a certain Chinese governmental
approval to enable the investor to complete its participation in
the Fundraise. At this stage, the process for receipt of such
governmental approval remains ongoing. The Company will apply for
admission to AIM of the New Common Shares ("Admission") on all
conditions of the Fundraise being satisfied. The Company will make
a further announcement in due course regarding the Chinese
governmental approval and timing of Admission.
The information communicated in this Announcement is inside
information for the purposes of Article 7 of Market Abuse
Regulation 596/2014 ("MAR"). For the purposes of MAR and Article 2
of Commission Implementing Regulation (EU) 2016/1055, this
announcement is being made on behalf of the Company by Craig
Crowell, Chief Financial Officer.
Enquiries:
HaloSource, Inc.
James Thompson, Chief Executive
Officer +1 425 419 2257
Craig Crowell, Chief Financial
Officer +1 425 419 2248
Hybridan LLP (Sole Broker)
Claire Noyce, Niall Pearson +44 203 764 2341
Liberum Capital Limited (NOMAD)
Richard Bootle, Jill Li, Steve
Pearce +44 203 100 2222
About HaloSource
HaloSource, Inc. innovates and integrates technologies to
deliver clean drinking water solutions to partners with trusted
brands around the world. The Company works with scientists and
industry experts across the globe in search of new ways to improve
drinking water quality and has been awarded more than 30 patents
for its ground breaking chemistries, which provide safe drinking
water for more than 10 million consumers globally. The Company's
class-leading HaloPure(R) Drinking Water technology has the highest
global certifications, including registration with the US EPA.
Founded in Seattle, Washington, HaloSource has grown to become
an influential leader in drinking water purification. HaloSource is
headquartered in the US with operations in China and in India.
Learn more about the Company's research and development and future
cutting edge technologies by visiting www.halosource.com.
HaloPure(R) is a registered trademark of HaloSource, Inc. All
other trademarks, brand names or product names belong to their
respective holders.
This document contains certain forward-looking statements
relating to the Company. The Company considers any statements that
are not historical facts as "forward-looking statements". They
relate to events and trends that are subject to risk and
uncertainty that may cause actual results and the financial
performance of the Company to differ materially from those
contained in any forward-looking statement. These statements are
made by management in good faith based on information available to
them and such statements should be treated with caution due to the
inherent uncertainties, including both economic and business risk
factors, underlying any such forward-looking information.
Hybridan LLP, which is regulated by the Financial Conduct
Authority, is acting exclusively for HaloSource in connection with
the Placing and no-one else and will not be responsible to anyone
other than HaloSource for providing the protections afforded to
customers of Hybridan LLP, or providing advice in connection with
the Fundraise or any transaction or arrangement referred to in this
announcement.
Liberum Capital Limited, which is regulated by the Financial
Conduct Authority, is acting exclusively for HaloSource in its role
as nominated adviser and no-one else and will not be responsible to
anyone other than HaloSource for providing the protections afforded
to customers of Liberum Capital Limited, or providing advice in
connection with the Fundraise or any transaction or arrangement
referred to in this announcement.
This announcement does not constitute, or form part of, an
offer, or solicitation of an offer, or invitation to subscribe for
or purchase any rights, ordinary shares or other securities of the
Company in the United States. In addition, the securities of the
Company to be issued in the Placing have not been, and will not be,
registered under the US Securities Act of 1933 (as amended) (the
"Securities Act") or the securities laws of any state or other
jurisdiction of the United States and may not be offered or sold or
delivered within, in or into the United States or to, or for the
account or benefit of, US Persons absent an applicable exemption
from the registration requirements of the Securities Act. There
will be no public offer of securities within the United States.
This information is provided by RNS
The company news service from the London Stock Exchange
END
UPDKDLFFDEFBBBV
(END) Dow Jones Newswires
May 18, 2017 02:01 ET (06:01 GMT)
Halosource CP S (LSE:HAL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Halosource CP S (LSE:HAL)
Historical Stock Chart
From Apr 2023 to Apr 2024